These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4318945)

  • 1. Altered properties of thymidine kinase after infection of mouse fibroblast cells with herpes simplex virus.
    Kit S; Dubbs DR; Anken M
    J Virol; 1967 Feb; 1(1):238-40. PubMed ID: 4318945
    [No Abstract]   [Full Text] [Related]  

  • 2. INHIBITION OF THYMIDINE KINASE FORMATION IN LM (TK-) CELLS SIMULTANEOUSLY INFECTED WITH VACCINIA AND A THYMIDINE KINASELESS VACCINIA MUTANT.
    MUNYON W; KIT S
    Virology; 1965 Jun; 26():374-7. PubMed ID: 14324004
    [No Abstract]   [Full Text] [Related]  

  • 3. PROPERTIES OF DEOXYTHYMIDINE KINASE PARTIALLY PURIFIED FROM NONINFECTED MOUSE FIBROBLAST CELLS.
    KIT S; DUBBS DR
    Virology; 1965 May; 26():16-27. PubMed ID: 14293309
    [No Abstract]   [Full Text] [Related]  

  • 4. Locating a nucleotide-binding site in the thymidine kinase of vaccinia virus and of herpes simplex virus by scoring triply aligned protein sequences.
    Gentry GA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6815-9. PubMed ID: 2995987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISOLATION AND PROPERTIES OF VACCINIA MUTANTS DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY.
    DUBBS DR; KIT S
    Virology; 1964 Feb; 22():214-25. PubMed ID: 14165326
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
    Jamieson AT; Gentry GA; Subak-Sharpe JH
    J Gen Virol; 1974 Sep; 24(3):465-80. PubMed ID: 4372299
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus.
    Coupar BE; Boyle DB; Both GW
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2299-309. PubMed ID: 2821171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.
    Bubley G; Crumpacker C; De Clercq E; Schnipper L
    Virology; 1983 Sep; 129(2):490-2. PubMed ID: 6312685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of vaccinia virus-induced thymidine kinase activity from [35S]methionine-labeled cells.
    Kit S; Jorgensen GN; Liav A; Zaslavsky V
    Virology; 1977 Apr; 77(2):661-76. PubMed ID: 193257
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-cytopathic, non-productive infection by herpes simplex viruses types 1 and 2.
    Garfinkle B; McAuslan BR
    Intervirology; 1973; 1(5-6):362-75. PubMed ID: 4361813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
    Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
    Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of herpesvirus thymidine kinase activity in LM(TK) cells transformed by ultraviolet light-irradiated herpes simplex virus.
    Kit S; Dubbs DR
    Virology; 1977 Jan; 76(1):331-40. PubMed ID: 65051
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T
    Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIOCHEMISTRY OF VACCINIA-INFECTED MOUSE FIBROBLASTS (STRAIN L-M). IV. 3H-THYMIDINE UPTAKE INTO DNA OF CELLS EXPOSED TO COLD SHOCK.
    KIT S; DUBBS DR
    Exp Cell Res; 1963 Aug; 31():397-406. PubMed ID: 14065130
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical classification of herpes simplex virus types 1 and 2, and of intermediate strains on the basis of different susceptibilities of thymidine kinase to thymidine analogues.
    Just I; Dundaroff S; Falke D
    Acta Virol; 1976 Feb; 20(1):31-9. PubMed ID: 7938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of cis-acting vaccinia virus DNA fragments promoting the expression of herpes simplex virus thymidine kinase by recombinant viruses.
    Vassef A; Mars M; Dru A; Plucienniczak A; Streeck RE; Beaud G
    J Virol; 1985 Jul; 55(1):163-72. PubMed ID: 2989553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location and cloning of the herpes simplex virus type 2 thymidine kinase gene.
    McDougall JK; Masse TH; Galloway DA
    J Virol; 1980 Mar; 33(3):1221-4. PubMed ID: 6245273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of human cellular thymidine kinase activity during abortive infection with herpes simplex virus type 2.
    Marcon MJ; Kucera LS
    Virology; 1979 Jul; 96(1):315-8. PubMed ID: 223308
    [No Abstract]   [Full Text] [Related]  

  • 19. Syntheses of virus-induced thymidine kinase and viral DNA in herpes simplex type 1 virus-infected chick embryo fibroblasts.
    Roubal J; Závada V; Zelená D; Hirsch I
    Acta Virol; 1977 May; 21(3):177-83. PubMed ID: 18914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
    Panicali D; Paoletti E
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):4927-31. PubMed ID: 6289324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.